Tuesday, September 21, 2010


Quick post on an interesting chart, CLDA

What I like about it...

  • Price has cleared a significant Volume by Price
  • Volume is constructive over the last 10 days...but more volume needs to come in to push it forward
  • It is solvent (but not profitable) and has already had a recent public offering.
  • Revenues are growing
What I don't like about it...

  • It's a biotech and subject to the vagaries of all biotechs.
  • It is not profitable, so there is a cash burn.
Charts like this in industries like this have to be allocated risk capital. (Click to make larger)

Position:  None